JPH0579649B2 - - Google Patents

Info

Publication number
JPH0579649B2
JPH0579649B2 JP57186885A JP18688582A JPH0579649B2 JP H0579649 B2 JPH0579649 B2 JP H0579649B2 JP 57186885 A JP57186885 A JP 57186885A JP 18688582 A JP18688582 A JP 18688582A JP H0579649 B2 JPH0579649 B2 JP H0579649B2
Authority
JP
Japan
Prior art keywords
plasma protein
protein fraction
aqueous solution
fraction
human plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57186885A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5883630A (ja
Inventor
Kei Enu Jii Hooru
Ei Fuooneru Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of JPS5883630A publication Critical patent/JPS5883630A/ja
Publication of JPH0579649B2 publication Critical patent/JPH0579649B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP57186885A 1981-10-29 1982-10-26 酢酸イオンを実質的に含有していない血漿蛋白質画分 Granted JPS5883630A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/316,201 US4391801A (en) 1981-10-29 1981-10-29 Plasma protein fraction substantially free of acetate ions
US316201 1981-10-29

Publications (2)

Publication Number Publication Date
JPS5883630A JPS5883630A (ja) 1983-05-19
JPH0579649B2 true JPH0579649B2 (en, 2012) 1993-11-04

Family

ID=23227983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57186885A Granted JPS5883630A (ja) 1981-10-29 1982-10-26 酢酸イオンを実質的に含有していない血漿蛋白質画分

Country Status (4)

Country Link
US (1) US4391801A (en, 2012)
JP (1) JPS5883630A (en, 2012)
AT (1) AT385661B (en, 2012)
DE (1) DE3238620A1 (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US8632785B2 (en) 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
KR100753765B1 (ko) * 2000-02-08 2007-08-31 알레간 인코포레이티드 보툴리눔 독소 약제학적 조성물
EP1565207B1 (en) * 2002-11-25 2006-04-12 Octapharma AG Prekallikrein depleted plasma derived albumin fraction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US2958628A (en) * 1957-02-21 1960-11-01 Cutter Lab Heat treatable plasma protein product and method of preparation
US3100737A (en) * 1958-02-05 1963-08-13 Auerswald Wilhelm Method of preparing a plasma protein solution free of active hepatitis virus and product produced thereby
JPS5620287B2 (en, 2012) * 1972-06-19 1981-05-13
JPS5417002B2 (en, 2012) * 1974-02-18 1979-06-27
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production

Also Published As

Publication number Publication date
ATA394982A (de) 1987-10-15
DE3238620A1 (de) 1983-05-11
US4391801A (en) 1983-07-05
JPS5883630A (ja) 1983-05-19
AT385661B (de) 1988-05-10

Similar Documents

Publication Publication Date Title
CA1142431A (en) Virus-inactivated hgi-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, for preparing same and leukopenia curative containing same
US4340589A (en) Antithrombin preparation and process for the production thereof
US5099003A (en) Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
DE3400413C2 (en, 2012)
US5122373A (en) Immunoglobulin-g-containing fraction
US4318902A (en) Concentrated immunoglobulin solution suited for intravenous administration
JPH03503287A (ja) 生体に適切なウィルス不活性化アルブミン
Dogon et al. Characterization of an antibacterial factor in human parotid secretions, active against Lactobacillus casei
JPS6030291B2 (ja) 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
HU182554B (en) Process for producing preparation of serum protein for intravenous application
US4137307A (en) Process for preparing haptoglobin aqueous solution using strong anion exchanger
JPH0579649B2 (en, 2012)
JPS58225023A (ja) α―１―プロテイナーゼ阻害剤の製法
US4061735A (en) Haptoglobin in aqueous solution and process for preparing the same
DE3643182A1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
JPS6236326A (ja) 造血器疾患治療剤
EP0011739B1 (en) Process for obtaining blood coagulation factor xiii derived from human placenta
EP0253313A2 (en) Process for heat treating chemically unmodified gamma-globulin
KR0168866B1 (ko) 푸린 유도체 및 글루타티온에 의해 안정화된 폴리헤모글로빈
DK166713B1 (da) Fremgangsmaade til inaktivering af stoffer, der foraarsager uforenelighedsreaktioner i immunglobulinholdige blodfraktioner til terapeutisk eller profylaktisk anvendelse samt fremstilling af en immunglobulinholdig blodfraktion
FI96918B (fi) Koostumus veriplasman stabiloimiseksi pastöroinnin aikana
EP0449897B1 (en) A pure factor i protein and a process for producing said protein
DE69130483T2 (de) Verbesserter blutersatz
SE451844B (sv) Glykoprotein, forfarande for framstellning derav samt terapeutiskt medel innehallande nemnda glykoprotein
JPS59501546A (ja) ガンマグロブリン含有組成物の製造法